Cancer Research UK sponsored the trial. Dr. Ferry reported grant support, honoraria, and an advisory relationship with AstraZeneca in the development of gefitinib.
AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY CONGRESS
More GI Oncology News
- AI-Assisted Colonoscopy Linked to Higher Rate of Benign Lesion Removal
- Screening Options for Rare Malignancies
- Low-Volume Bowel Prep Easier, as Effective as Standard Prep in Hospitalized Patients
- GLP-1 RAs Reduce Early-Onset CRC Risk in Patients With Type 2 Diabetes
- AI Tool Helps Detect, Differentiate Pancreatic Lesions During Endoscopic Ultrasound
- FIT Completion and Yield Similar in Younger and Older Adults
- Value of AI-Aided Colonoscopy on Advanced Neoplasia Detection Unclear
- When It Comes to Polyp Diagnosis With CADx, Location Matters
Management of malignant alimentary tract obstruction

Question 1 of 4